Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D003864:Depression, Chemical; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects*; D008099:Liver / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D010208:Papaverine / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors*; D051381:Rats; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology*
D014970:Xanthines; D002110:Caffeine; D000324:Adrenocorticotropic Hormone; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases